News

Will support pharma manufacturers with digital health and commercialization services

Company unifies its patient support services

Study will implement AI-powered technology approaches in support of migraine therapy

A global push for getting corporations to commit to electric vehicles catches hold among big pharma companies

Production of the key component of gene therapies and certain vaccines for Covid-19 hampered by insufficient manufacturing capacity, according to GlobalData

Vaccine maker will use CDMO’s South Korean facilities to support additional Covid doses

Expansion features a new lyophilization center to meet point-of-care demand

Collaboration to focus on merging data with machine learning to make healthcare content more accessible

Pact between CPI and Cambridge Design Partnership aims to streamline the innovation-to-commercialization journey

Big techs such as Amazon and Uber could help drive machinery surge

Major pharmaceutical transporter in Latin America will nearly double freighter capacity by 2023

Company's container maintains a -70°C temperature for at least 240 hours

Third deal in two months for the CRO expands capabilities in cell and gene therapy

Pharma and nutraceuticals collaborate, as deal introduces logistics program to Bonne Santé Group

Expansion establishes role it plays in the oncology sector, company suggests

Pair of life-sciences data powerhouses are immersed in dispute over their respective data services for pharma sales and marketing

Research report: 41% of US cannabis consumers self-identify as medical consumers

Pauses per manufacturer due to label-printing problems occur just under six times a year, on average, report finds

Portrix acquisition strengthens company’s supply chain presence

Marks the first US Covid vaccine authorized for this age group

New sterile production area at Italy facility aims to benefit biologics manufacturing, such as BSL vaccines

Company also plans to design a manufacturing site for future mRNA vaccines and therapeutics

Will use new facility in Belgium for commercial production of plasmid DNA

Data will be provided on a rolling basis, as the companies receive the latest numbers

Luxembourg-based manufacturer attributes increase in demand to the current pandemic

CDMO giant invests nearly $1 billion in Switzerland and New Hampshire sites

The drive for “vaccine equity” around the world is strengthening efforts to limit patent protections on innovative drugs and vaccines to combat Covid

Purchase of technology-powered CRO grows Aixial's offerings in clinical operations and product development